Oscar Lambret Center in France Installs Second Accuray Radixact® System, the Hospital's Fifth Accuray Radiation Therapy Delivery System

Thursday, November 17, 2022

Accuray Incorporated announced today that the Oscar Lambret Center in Lille, France has installed its second Radixact® System and the hospital's fifth Accuray radiation therapy delivery system. The hospital has enhanced both Radixact Systems with the addition of the Accuray-only ClearRT™ Helical Fan-Beam kVCT Imaging and Synchrony® technologies, applications designed to improve treatment outcomes and versatility in the types of diseases that can be treated.

ClearRT integrated with Synchrony on the Radixact System provides the tools to increase the precision and accuracy of treatments and as a result, expands the type of external beam radiation therapy that can be delivered with one system. From extremely precise and accurate conventionally fractionated image-guided intensity-modulated radiation therapy (IG-IMRT) to ultra-hypofractionated stereotactic body radiation therapy (SBRT) treatments, the care team has the flexibility to choose the modality that is most appropriate for each patient based on a range of factors including their medical condition and history, age and lifestyle.

"We value our long-standing relationship with the Oscar Lambret team and look forward to partnering with them for many years to come. I believe Accuray technologies support the hospital's patient-focused mission and will enable them to achieve the highest levels of cancer care while increasing the number of people within their community who can be helped on a daily basis," said Suzanne Winter, president and CEO of Accuray.

The Oscar Lambret Center is part of Unicancer, the only French hospital network dedicated 100% to cancer care, research and education. The hospital, in operation for more than 65 years, has pioneered the use of numerous diagnosis and treatment modalities to improve the care of their patients. The medical care team is a long-term user of Accuray technology, having treated their first patients with the Accuray CyberKnife® System in 2007. The team continued its legacy of innovation in 2013 when they treated the first patient in the world with the TomoHDA™ System.

"The Oscar Lambret Center is recognized for its scientific and technical expertise. We are dedicated to providing personalized, high-quality cancer care based on the latest research and most advanced treatment options, such as the Radixact System with ClearRT and Synchrony," said Xavier Mirabel, M.D., head of the radiation therapy department, Oscar Lambret Center. "The technologies offer many benefits including the ability to see tumors more clearly and target them more precisely by adapting to tumor or patient motion."

The Oscar Lambret team selected the Radixact System, the latest generation of the TomoTherapy® platform, with ClearRT and Synchrony to offer their patients even more precise radiation therapy treatments on a daily basis and improve the patient experience. The system provides an option for almost any tumor that would benefit from radiation therapy, including those that move, and will be the hospital's primary device for the treatment of cancer in the head and neck and pelvis.

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare CNO SummitHealthcare CMO Summit